Metacognitive Therapy

Wells, Adrian; Simons, Michael

doi:10.1002/9781118528563.wbcbt06

Cited by 8 publications

(6 citation statements)

References 48 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One is metacognitive therapy (MCT), which was first developed to address impairments of cognition that occur in several stress-related disorders such as depression, anxiety, PTSD, and obsessive-compulsive disorder. [147][148][149][150][151][152] Metacognitive therapy has been described a hybrid of cognitive-behavioral therapy and psychoeducation 153,154 and has been shown to be efficacious in reducing schizophrenia-related anxiety and depression symptoms. 155,156 Another method is metacognitive strategy instruction, which was found to be helpful for those with below-average decision-making performance but not for those with average or above-average decision-making performance.…”

Section: Social Cognition Metacognitionmentioning

confidence: 99%

“…, 156 Another method is metacognitive strategy instruction, which was found to be helpful for those with below-average decision-making performance but not for those with average or above-average decision-making performance 136 . Recent metacognitive models have been directed toward addiction, 148 , 157 but formal clinical trials in substance use disorders using MCT or metacognitive strategy instruction are not yet available.…”

Section: Social Cognitionmentioning

confidence: 99%

See 1 more Smart Citation

Cognitive impairment in substance use disorders

Ramey

Regier

2018

CNS Spectr.

View full text Add to dashboard Cite

Cognitive impairments in substance use disorders have been extensively researched, especially since the advent of cognitive and computational neuroscience and neuroimaging methods in the last 20 years. Conceptually, altered cognitive function can be viewed as a hallmark feature of substance use disorders, with documented alterations in the well-known “executive” domains of attention, inhibition/regulation, working memory, and decision-making. Poor cognitive (sometimes referred to as “top-down”) regulation of downstream motivational processes—whether appetitive (reward, incentive salience) or aversive (stress, negative affect)—is recognized as a fundamental impairment in addiction and a potentially important target for intervention. As addressed in this special issue, cognitive impairment is a transdiagnostic domain; thus, advances in the characterization and treatment of cognitive dysfunction in substance use disorders could have benefit across multiple psychiatric disorders. Toward this general goal, we summarize current findings in the abovementioned cognitive domains of substance use disorders, while suggesting a potentially useful expansion to include processes that bothprecede(precognition) andsupersede(social cognition) what is usually thought of as strictly cognition. These additional two areas have received relatively less attention but phenomenologically and otherwise are important features of substance use disorders. The review concludes with suggestions for research and potential therapeutic targeting of both the familiar and this more comprehensive version of cognitive domains related to substance use disorders.

show abstract

Section: Social Cognition Metacognitionmentioning

confidence: 99%

Section: Social Cognitionmentioning

confidence: 99%

Cognitive impairment in substance use disorders

Ramey

Regier

2018

CNS Spectr.

View full text Add to dashboard Cite

show abstract

“…DM is not the same as mindfulness meditation. Wells [4,50] explained that while there is some overlap between the two, DM differs from mindfulness meditation in a number of ways. DM involves specific awareness of cognition rather than the broader context of attention to present moment experiences.…”

Section: Metacognitive Therapy (Mct)mentioning

confidence: 99%

A Review of Metacognition in the diagnosis and treatment of Obsessive Compulsive Disorder

Ninawe¹,

Shroff²

2017

IJMH

View full text Add to dashboard Cite

Cognitive theories are more prominent among the theories that explain the etiology and maintenance of OCD as well as among those that offer treatment options. Metacognition is a concept included within the newer theories and models within the cognitive perspective. This is a review of literature with particular focus on the concept of metacognition in cognitive models of OCD, metacognitive measurement tools and metacognitive treatment options. Although there have been metacognitive elements within the cognitive theories for a long time, it is only recently that they have been given importance and considered as separate variables. Research suggests that metacognition plays a central role in the etiology and maintenance of OCD. There are multiple valid and reliable metacognitive tools that are available for diagnostic and treatment purposes. Metacognitive treatments offer promising results for patients with OCD. However, there is a need for more robust empirical evidence using large-scale and longitudinal studies to establish its role more concretely.

show abstract

“…Segal, Gemar, & Williams, 1999, Segal et al, 2006). The flood of negative thoughts that occur once the schema is activated and what a patient does with such thoughts (e.g., ruminating on them vs. acceptance; Wells, in press) may be the most important predictor of relapse. Nonetheless, if these findings are replicated and a shift in the organisation of self-representation is an important mechanism of long-term treatment change, then treatments can target this explicitly…”

Section: Closing the Gap Between Science And Practicementioning

confidence: 99%

Psychological treatments: Putting evidence into practice and practice into evidence.

Dozois

2013

Canadian Psychology / Psychologie canadienne

View full text Add to dashboard Cite

In June 2011, the Canadian Psychological Association (CPA) Board of Directors launched a task force on the evidencebased practice of psychological treatments. The purpose of this task force was to operationalize what constitutes evidence-based practice in psychological treatment, to make recommendations about how psychologists can best integrate evidence into practice, and to disseminate information to consumers about evidence-based interventions. An important impetus for this task force was the continuing and widening scientist-practitioner gap. There are both barriers and opportunities when it comes to promoting greater reliance on the scientific literature and greater uptake of empirically supported treatments among practitioners. Two main factors prevail. For one, there is considerable controversy over what constitutes best evidence. The second is that researchers often do not communicate their findings in a manner that effectively translates their results from the laboratory to the clinic. It is crucial that we not only make practice evidence-based but also make evidence practice-based. In this article, I focus on current issues and opportunities with respect to evidencebased practice and identify strategies for closing the gap between research and practice.

show abstract

Metacognitive Therapy

Cited by 8 publications

References 48 publications

Cognitive impairment in substance use disorders

Cognitive impairment in substance use disorders

A Review of Metacognition in the diagnosis and treatment of Obsessive Compulsive Disorder

Psychological treatments: Putting evidence into practice and practice into evidence.

Contact Info

Product

Resources

About